Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Weinberg

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancerBenjamin A Weinberg, John L Marshall, Marion Hartley, et al.
Oncotarget|December 29, 2025
Nerofe+ldDox releases c-Jun from nuclear ST2 to reprogram the immune microenvironment in mtKRAS tumorsJoel Ohana, Uziel Sandler, Benjamin A Weinberg, et al.
Oncology (Williston Park, N.Y.)|November 18, 2015
Current Standards and Novel Treatment Options for Metastatic Pancreatic AdenocarcinomaBenjamin A Weinberg, Cinthya S Yabar, Jonathan R Brody, et al.
Surgical Oncology|October 18, 2023
Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysisAli Alqahtani, Abdurahman Alloghbi, Philip Coffin, et al.
Clinical Advances in Hematology & Oncology : H&O|November 10, 2023
Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancerPaul E Sackstein, Nikita Chintapally, Molly Wilgucki, et al.
NPJ Precision Oncology|April 6, 2024
Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tailMaen Abdelrahim, Abdullah Esmail, Anup Kasi, et al.
Biomedicines|September 28, 2021
Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer MetastasisJerry Xiao, Paula R Pohlmann, Claudine Isaacs, et al.
Cancers|February 13, 2025
Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic AdenocarcinomasJerry Xiao, Reetu Mukherji, George Sidarous, et al.
The Oncologist|April 29, 2018
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be EnoughBenjamin A Weinberg, Joanne Xiu, Jimmy J Hwang, et al.
Journal of Gastrointestinal Oncology|January 18, 2020
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancersKabir Mody, Jason Starr, Michelle Saul, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancerBenjamin A Weinberg, John L Marshall, Marion Hartley, et al.
Oncotarget|December 29, 2025
Nerofe+ldDox releases c-Jun from nuclear ST2 to reprogram the immune microenvironment in mtKRAS tumorsJoel Ohana, Uziel Sandler, Benjamin A Weinberg, et al.
Oncology (Williston Park, N.Y.)|November 18, 2015
Current Standards and Novel Treatment Options for Metastatic Pancreatic AdenocarcinomaBenjamin A Weinberg, Cinthya S Yabar, Jonathan R Brody, et al.
Surgical Oncology|October 18, 2023
Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysisAli Alqahtani, Abdurahman Alloghbi, Philip Coffin, et al.
Clinical Advances in Hematology & Oncology : H&O|November 10, 2023
Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancerPaul E Sackstein, Nikita Chintapally, Molly Wilgucki, et al.
NPJ Precision Oncology|April 6, 2024
Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tailMaen Abdelrahim, Abdullah Esmail, Anup Kasi, et al.
Biomedicines|September 28, 2021
Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer MetastasisJerry Xiao, Paula R Pohlmann, Claudine Isaacs, et al.
Cancers|February 13, 2025
Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic AdenocarcinomasJerry Xiao, Reetu Mukherji, George Sidarous, et al.
The Oncologist|April 29, 2018
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be EnoughBenjamin A Weinberg, Joanne Xiu, Jimmy J Hwang, et al.
Journal of Gastrointestinal Oncology|January 18, 2020
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancersKabir Mody, Jason Starr, Michelle Saul, et al.
Pageof 7